|
Re: Mannkind's Afrezza May Be Half As Effective As Current Injectable Insulins
|
5
|
Mannkind
|
Aug 15, 2013 03:43PM
|
|
Re: Mannkind's Afrezza May Be Half As Effective As Current Injectable Insulins
|
|
Mannkind
|
Aug 15, 2013 03:48PM
|
|
Re: MannKind's Afrezza And The Oramed Threat
|
3
|
Mannkind
|
May 23, 2013 08:39AM
|
|
Re: Mannkind Files $500 Million Mixed-Securities Shelf Registration >MNKD
|
|
Mannkind
|
Sep 01, 2012 06:52AM
|
|
Re: Mannkind Files $500 Million Mixed-Securities Shelf Registration >MNKD
|
|
Mannkind
|
Aug 31, 2012 05:07PM
|
|
Re: Mannkind Files $500 Million Mixed-Securities Shelf Registration >MNKD
|
|
Mannkind
|
Aug 31, 2012 05:20PM
|
|
Re: Mannkind Files $500 Million Mixed-Securities Shelf Registration >MNKD
|
|
Mannkind
|
Aug 31, 2012 05:23PM
|
|
Re: Mannkind Files $500 Million Mixed-Securities Shelf Registration >MNKD
|
|
Mannkind
|
Aug 31, 2012 05:24PM
|
|
Re: Mannkind Files $500 Million Mixed-Securities Shelf Registration >MNKD
|
|
Mannkind
|
Aug 31, 2012 05:29PM
|
|
Re: Mannkind Files $500 Million Mixed-Securities Shelf Registration >MNKD
|
|
Mannkind
|
Aug 31, 2012 05:36PM
|
|
Re: Mannkind Files $500 Million Mixed-Securities Shelf Registration >MNKD
|
|
Mannkind
|
Aug 31, 2012 06:14PM
|
|
Re: MannKind Cut to Neutral From Buy by BofA-Merrill Lynch
|
|
Mannkind
|
Jun 07, 2013 10:25AM
|
|
Re: Mannkind Corp.:Bearish
|
2
|
Mannkind
|
Jul 29, 2013 12:35PM
|
|
Re: MannKind Completes Phase 3 Clinical Study Of AFREZZA In Patients With Type 1 Dia
|
|
Mannkind
|
May 31, 2013 04:21PM
|
|
Re: MannKind announces $160M debt financing
|
|
Mannkind
|
Jul 02, 2013 10:56AM
|
|
Re: MannKind announces $160M debt financing
|
|
Mannkind
|
Jul 01, 2013 09:38AM
|
|
Re: Lyxumia® is First Diabetes Therapy of its Class Approved in Japan for use in Com
|
1
|
Mannkind
|
Jun 28, 2013 10:12AM
|
|
Re: Little nervous
|
|
Mannkind
|
Aug 16, 2013 10:23AM
|
|
Re: Linking HF to clinical trials
|
|
Mannkind
|
May 02, 2013 09:25AM
|
|
Re: Leaving the board! To OPC/Stizzer
|
5
|
Mannkind
|
Aug 22, 2012 12:07PM
|
